October 3, 2017 / 6:51 AM / in 18 days

BUZZ-India's Dr.Reddy's Labs rises on drug launch in U.S. market

** Drugmaker Dr.Reddy’s Laboratories Ltd shares up as much as 3.7 pct to 2,415 rupees, their highest since Sept. 28

** Company launched Sevelamer Carbonate Tablets, a drug used to treat severe kidney disease, in the U.S. market on Friday

** The launch can add 7 pct to company’s FY18 earnings per share - Jefferies

** REDY’s new launch and the recent win in a lawsuit over opioid addiction treatment drug Suboxone highlight the strength of complex product launches from the company; however concerns on facility standards still remain - Jefferies

** Dr. Reddy’s was one of the drugmakers sued by Indivior’s U.S. subsidiary alleging infringement of a patent regarding Suboxone

** Jefferies retained “underperform” rating with a price target of 2,150 rupees

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below